DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but not for resolution of lyme disease

Infection and Immunity

Volumn 69, Issue 4, 2001, Pages 2130-2136

  Wallich, R ^a   Siebers, A ^a   Jahraus, O ^a   Brenner, C ^a   Stehle, T ^a   Simon, M M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DNA VACCINE; ELONGATION FACTOR 1; GENE PRODUCT; POLYPEPTIDE; PROTEIN A; PROTEIN C; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; FEMALE; FUSION GENE; GENE CONTROL; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGENICITY; LYME DISEASE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI GROUP; HUMANS; IMMUNIZATION; LIPOPROTEINS; LYME DISEASE; LYME DISEASE VACCINES; MICE; MICE, INBRED BALB C; MICE, SCID; TUMOR CELLS, CULTURED; VACCINES, DNA;

EID: 0035084743     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.4.2130-2136.2001     Document Type: Article

References (35)

1. Spirochetes isolated from the blood of two patients with Lyme disease
2. Borrelia burgdorferi strain-specific ospC-mediated immunity in mice
3. Lyme disease - A tick-borne spirochetosis?
4. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine
5. Arthropod-specific and host-specific gene-expression by Borrelia burgdorferi
6. Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity
7. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites
8. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: Evidence for a conformational protective epitope in OspC
9. Establishment and characterization of BALB/c lymphoma lines with B cell properties
10. Characterization of Borrelia burgdorferi associated antigens by monoclonal antibodies
11. Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab
12. An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi
13. Retroviral immortalization of phagocytic and dendritic cell clones as a tool to investigate functional heterogeneity
14. pEF-BOS, a powerful mammalian expression vector
15. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: Exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease
16. Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. Burgdorferi infection
17. Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen
18. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding
19. Loss of pathogenic potential after cloning of the low-passage Borrelia burgdorferi ZS7 tick isolate: A cautionary note
20. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter
21. Recombinant outer surface protein A of Borrelia burgdorferi induces antibodies protective against spirochetal infection in mice
22. Lyme disease
23. The spirochetal etiology of Lyme disease
24. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant
25. Genetic immunization is a simple method for eliciting an immune response
26. Polymorphism in ospC gene of Borrelia burgdorferi and immunoreactivity of OspC protein: Implications for taxonomy and for use of OspC protein as a diagnostic antigen
27. Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo
28. Improvement of the immune response against plasmid DNA encoding OspC of Borrelia by an ER-targeting leader sequence
29. Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development
30. An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis
31. Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi
32. Direct gene transfer into mouse muscle in vivo
33. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC
34. Therapeutic passive vaccination against chronic Lyme disease in mice
35. Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo